trial
as of 2026-07-01Comparison of Cognitive Functions of Schizophrenic Patients Treated With Sertindole Versus Risperidone
NCTId NCT00480844
at a glance
Phase 4 · Unknown
Enrollment 60 (estimated)
Sponsored by Sheba Medical Center
Primary completion 2011-10
Synthesized from structured facts only — each point cited above.
Design & status
Phase
Phase 4
Status
Unknown
Enrollment
60 (estimated)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
None
Start
2008-10
Primary completion
2011-10
Eligibility
ALL · 18 Years · 65 Years
Interventions & indications
Sponsors
Sheba Medical CenterLead Sponsor
Investigators
1
Mark Weiser, MDPrincipal Investigator
Sites
3 total
Ramat Gan, IsraelBeer-Yaakov, IsraelJerusalem, Israel
Facts & assertions
4 sourced
Enrollment
60
Phase
PHASE4
Primary Completion Date
2011-10
Status
UNKNOWN
relationships
The graph out of here
drug
drug
drug
lead_sponsor
company
indication
investigator
person